Diabetes Care in the Philippines.
Diabetes is increasing at an alarming rate in Asian countries including the Philippines. Both the prevalence and incidence of type 2 diabetes (T2D) continue to increase with a commensurate upward trend in the prevalence of prediabetes.



The aim of this study was to review the prevalence of diabetes in the Philippines and to describe extensively the characteristics of diabetes care in the Philippines from availability of diagnostics tests to the procurement of medications.



A literature search was performed using the search words diabetes care and Philippines. Articles that were retrieved were reviewed for relevance and then synthesized to highlight key features.



The prevalence of diabetes in the Philippines is increasing. Rapid urbanization with increasing dependence on electronic gadgets and sedentary lifestyle contribute significantly to this epidemic. Diabetes care in the Philippines is disadvantaged and challenged with respect to resources, government support, and economics. The national insurance system does not cover comprehensive diabetes care in a preventive model and private insurance companies only offer limited diabetes coverage. Thus, most patients rely on "out-of-pocket" expenses, namely, laboratory procedures and daily medications. Consequently, poor pharmacotherapy adherence impairs prevention of complications. Moreover, behavioral modifications are difficult due to cultural preferences for a traditional diet of refined sugar, including white rice and bread.



Translating clinical data into practice in the Philippines will require fundamental and transformative changes that increase diabetes awareness, emphasize lifestyle change while respecting cultural preferences, and promote public policy especially regarding the health insurance system to improve overall diabetes care and outcomes.
Division of Endocrinology, Department of Internal Medicine, Cebu Doctors University College of Medicine, Cebu Doctors University Hospital, Cebu, Philippines. Electronic address: docgerrytan@alumni.mayo.edu.
Gerry H
GH
Tan
D003695:Delivery of Health Care / Q000191:economics*; D003924:Diabetes Mellitus, Type 2 / Q000191:economics / Q000453:epidemiology / Q000628:therapy*; D005382:Financing, Personal; D017048:Health Care Costs; D006295:Health Resources; D006297:Health Services Accessibility; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000191:economics / Q000600:supply & distribution; D015994:Incidence; D007348:Insurance, Health; D010679:Philippines / Q000453:epidemiology; D015995:Prevalence; D011640:Public Policy
D007004:Hypoglycemic Agents
Philippines; Southeast Asia; diabetes; diabetes care; type 2 diabetes